InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（2 笔）
内部人交易记录
高级管理人员已披露买入
2
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Sherman Jeffrey W, 董事. Officer active across 6 companies, notably Strongbridge Biopharma plc. Cumulatively, 30 reports have been recorded. Split: 2 buys · 2 sells. Total volume traded: €4.6m. Activity tracked since 14 May 2021. The latest transaction was disclosed on 27 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sherman Jeffrey W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报30 总计
5,000 股@ US$5.00100.0% 占其流量Common StockSEC:0001193125-26-085510:0
标准退出：2026年5月28日 (T+90)
47,040 股@ US$6.6696.7% 占其流量Common StockSEC:0001867096-25-000145:0
50,000 股0Common StockSEC:0001867096-25-000110:0
50,000 股0Common StockSEC:0001867096-24-000108:0
6,502 股Common StockSEC:0001867096-24-000043:0
5,400 股@ US$1.87100.0% 占其流量Common StockSEC:0001867096-23-000154:0
标准退出：2024年2月25日 (T+90)
2,655 股@ US$116.505.8% 占其流量Ordinary SharesSEC:0001209191-23-052358:0
2,165 股0Ordinary SharesSEC:0001209191-23-048609:0
42,500 股0Common StockSEC:0001867096-23-000091:0
33,795 股0Ordinary SharesSEC:0001209191-23-003738:0
3,368 股@ US$113.057.1% 占其流量Ordinary SharesSEC:0001209191-23-003146:0
51,132 股Ordinary SharesSEC:0001209191-23-002439:0
21,772 股Ordinary SharesSEC:0001209191-23-000939:0
8,531 股0Ordinary SharesSEC:0001209191-22-060901:0
15,000 股0Common StockSEC:0001867096-22-000095:0
42,009 股@ US$110.02196.8% 占其流量Ordinary SharesSEC:0001209191-22-023841:0
12,304 股0Ordinary SharesSEC:0001209191-22-020259:0
5,354 股0Ordinary SharesSEC:0001209191-22-004632:0
10,729 股0Ordinary SharesSEC:0001209191-22-002285:0
10,729 股@ US$7.611.4% 占其流量Ordinary SharesSEC:0001209191-21-062085:0
64,258 股Ordinary SharesSEC:0001179110-21-009279:0
50,378 股Common StockSEC:0000899243-21-039322:0
17,763 股@ US$2.0646.2% 占其流量Ordinary SharesSEC:0001179110-21-009221:0
4,042 股0Ordinary SharesSEC:0001209191-21-057450:0
7,257 股0Ordinary SharesSEC:0001209191-21-048791:0
30 条申报中的 25 条
About Sherman Jeffrey W
SHERMAN JEFFREY W is Director and Executive Vice President, Chief Medical Officer. He has 30 filings in total, and across the 30 sampled filings the transactions run from 2016-01-05 to 2026-03-02, with EUR 30411 of purchases and EUR 4888957 of sales; the filings relate to Horizon Therapeutics Public Ltd Co, Xeris Biopharma Holdings, Inc., Strongbridge Biopharma plc, Horizon Pharma plc and Larimar Therapeutics, Inc.
